Philippe Prokocimer

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Philippe Prokocimer, Carisa De Anda, Edward Fang et al. · JAMA · 2013 · 352 citations

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases · 2014 · 301 citations

Antimicrobial Susceptibility, Antibiotics, Skin-structure Infections +8

Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*

Jean Chastre, Richard G. Wunderink, Philippe Prokocimer et al. · Critical Care Medicine · 2008 · 241 citations

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.

W. L. Peterson, David Y. Graham, Barry J. Marshall et al. · PubMed · 1993 · 216 citations

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey et al. · Antimicrobial Agents and Chemotherapy · 2014 · 140 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +17